Growth Metrics

OmniAb (OABI) Cash & Equivalents (2021 - 2026)

OmniAb (OABI) reported Cash & Equivalents of $22.9 million for Q1 2026, up 110.62% year-over-year from $10.9 million in Q1 2025, and up 14.25% on a QoQ basis from $20.1 million in Q4 2025.

OmniAb (OABI) has 6 years of Cash & Equivalents data on file, last reported at $22.9 million in Q1 2026.

  • Quarterly Cash & Equivalents rose 110.62% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.9 million (up 110.62% YoY) and the FY2025 annual result came in at $20.1 million, up 13.99% from the prior year.
  • Cash & Equivalents rose to $22.9 million in Q1 2026 per OABI's latest filing, from $20.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $33.4 million in Q4 2022 and bottomed at $19847.0 in Q3 2022.
  • The 5-year median for Cash & Equivalents is $20.1 million (2025), against an average of $17.7 million.
  • The widest annual swing landed in 2022, when Cash & Equivalents slumped 94.52%; it then surged 106943.89% in 2023.
  • Tracing OABI's Cash & Equivalents over 5 years: stood at $33.4 million in 2022, then plunged by 51.01% to $16.4 million in 2023, then gained by 7.69% to $17.6 million in 2024, then rose by 13.99% to $20.1 million in 2025, then rose by 14.25% to $22.9 million in 2026.
  • Per Business Quant, the three latest OABI Cash & Equivalents figures stand at $22.9 million (Q1 2026), $20.1 million (Q4 2025), and $28.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.91 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.49 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.96 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.71 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 22.94 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.94 Mn
Dec 31, 2025 20.08 Mn
Sep 30, 2025 28.54 Mn
Jun 30, 2025 18.28 Mn
Mar 31, 2025 10.89 Mn
Dec 31, 2024 17.62 Mn
Sep 30, 2024 27.24 Mn
Jun 30, 2024 20.79 Mn
Mar 31, 2024 19.06 Mn
Dec 31, 2023 16.36 Mn
Sep 30, 2023 21.25 Mn
Jun 30, 2023 20.99 Mn
Mar 31, 2023 22.91 Mn
Dec 31, 2022 33.39 Mn
Sep 30, 2022 19,847.00
Jun 30, 2022 159,194.00
Mar 31, 2022 434,629.00
Sep 30, 2021 362,203.00
Jun 30, 2021 36,145.00